• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

RCT Results: Does Self-Monitoring Blood Pressure in Hypertensive Pregnancies Improve Blood Pressure Control?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • The effectiveness of self-monitoring blood pressure (SMBP) during pregnancy is not well-established
  • Chappell et al. (JAMA, 2022) evaluated the effect of SMBP on blood pressure control and related outcomes among pregnant women with hypertension

METHODS:

  • Unblinded, randomized clinical trial
    • Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension 2 (BUMP 2) trial
  • Participants
    • Chronic hypertension (enrolled up to 37 weeks) or
    • Gestational hypertension (enrolled between 20 to 37 weeks)
  • Interventions
    • SMBP using a validated monitor and a secure telemonitoring system in addition to usual care
    • Usual care alone: Blood pressure measured by health care professionals at regular antenatal clinics
  • Sample size
    • Estimated 256 per group to detect a 5 mm Hg difference in systolic BP
    • 90% power and 5% level of significance (2-sided), accounting for 15% attrition
    • Sample size total increased to 600 to retain power in the cohorts of individuals with chronic and gestational hypertension
  • Primary outcome
    • Difference in mean systolic blood pressure recorded by health care professionals between randomization and birth

RESULTS:

  • Chronic hypertension: 444 participants (primary outcome data available)
    • Mean age: 36 years | mean gestation at entry: 20 weeks
  • Gestational hypertension: 377 participants (primary outcome data available)
    • Mean age 34 years | mean gestation at entry: 33 weeks
  • Mean systolic blood pressure: There was no statistically significant difference in either cohort
    • Chronic hypertension
      • SMBP: 133.8 mm Hg
      • Usual care: 133.6 mm Hg
      • Adjusted mean difference 0.03 mm Hg (95% CI, −1.73 to 1.79)
    • Gestational hypertension
      • SMBP: 137.6 mm Hg
      • Usual care: 137.2 mm Hg
      • Adjusted mean difference −0.03 mm Hg (95% CI, −2.29 to 2.24)
  • Serious adverse events: There was no statistically significant difference in either cohort
    • Chronic hypertension
      • SMBP: 4
      • Usual care: 2
    • Gestational hypertension
      • SMBP: 4
      • Usual care: 1
  • ‘White coat effect’
    • Approximately 25% of participants recorded only normal BP at home but had elevated clinic pressures
    • However, there was no difference in medications between SMBP and clinic monitoring, suggesting patients were treated based on clinic and not SMBP information

CONCLUSION:

  • For individuals with hypertension during pregnancy, self-monitoring blood pressure did not improve blood-pressure control compared with usual care
  • The authors state

The strengths of this trial included the intervention being developed iteratively with the input of pregnant individuals and behavioral change experts

It was appropriately powered including separately for chronic and gestational hypertension, undertaken in multiple maternity units across England with diverse sociodemographic characteristics (including a substantial proportion from non-White racial and ethnic groups), with recruitment completed prior to the COVID-19 pandemic

The results may, therefore, be generalizable to populations beyond those in the study

Learn More – Primary Sources:

Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Results of the TASMINH4 Study: Does Self-Monitoring Blood Pressure Lead to Better Hypertension Outcomes?
Does Postpartum BP Self-Management Reduce Long-Term Adverse Events in Women with Hypertensive Disorders of Pregnancy
Can A Mobile Technology Assisted BP Self-Monitoring Program Improve BP Control?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site